ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,601Medicare Part D Prescriptions Filled, Including Refills

Rank: 272 out of 939

$371K Total Retail Price of All Prescriptions

Rank: 388 out of 939

366 Patients Receiving at Least One Drug in Part D
80%Patients 65 Years and Older
46% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

4% of this provider’s 366 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

4% of this provider’s 366 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

3% of this provider’s 7,921 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

17% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$39 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
LEVOTHYROXINE SODIUM 564 475 1 4
SIMVASTATIN 473 407 2 2
AMLODIPINE BESYLATE 388 352 3 6
OMEPRAZOLE 321 271 4 5
HYDROCHLOROTHIAZIDE 274 251 5 12
POTASSIUM CHLORIDE 255 208 6 9
FUROSEMIDE 239 200 7 7
LISINOPRIL-HYDROCHLOROTHIAZIDE 197 142 8 23
CITALOPRAM HBR 193 150 9 15
METFORMIN HCL 173 112 10 8
TRAMADOL HCL 151 136 11 16
GABAPENTIN 132 122 12 11
GLIMEPIRIDE 129 90 13 37
TRAZODONE HCL 129 89 13 26
FLUTICASONE PROPIONATE 125 98 15 43
LISINOPRIL 125 85 15 3
LOSARTAN-HYDROCHLOROTHIAZIDE 114 102 17 55
ATENOLOL 107 106 18 19
NEXIUM 106 61 19 18
LOVASTATIN 105 97 20 46
ATORVASTATIN CALCIUM 103 82 21 22
FLUOXETINE HCL 101 60 22 47
AMLODIPINE BESYLATE-BENAZEPRIL 101 89 22 58
MELOXICAM 100 83 24 14
WARFARIN SODIUM 96 81 25 17
PRAVASTATIN SODIUM 94 86 26 13
GEMFIBROZIL 93 93 27 100
METOPROLOL SUCCINATE 88 81 28 21
DONEPEZIL HCL 87 87 29 30
RANITIDINE HCL 80 66 30 35
METFORMIN HCL ER 77 51 31 76
TERAZOSIN HCL 75 65 32 114
ALLOPURINOL 72 63 33 31
ZOLPIDEM TARTRATE 72 66 33 20
GLYBURIDE-METFORMIN HCL 69 50 R 35 98
DIOVAN HCT 64 43 36 74
TAMSULOSIN HCL 63 63 37 27
MIRTAZAPINE 62 56 38 56
METOPROLOL TARTRATE 62 61 38 10
DOXYCYCLINE HYCLATE 61 45 40 84
CLONIDINE HCL 61 56 40 39
TRIAMTERENE-HCTZ 58 41 42 33
CYCLOBENZAPRINE HCL 57 17 R 43 36
CIPROFLOXACIN HCL 57 48 43 54
AMITRIPTYLINE HCL 56 54 R 45 38
LOSARTAN POTASSIUM 55 53 46 29
SPIRONOLACTONE 55 55 46 71
AZITHROMYCIN 54 45 48 32
ROPINIROLE HCL 53 47 49 78
PAROXETINE HCL 52 40 50 70
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 19, 2011.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.